Dodge & Cox’s Gsk PLC Position
Does Dodge & Cox own Gsk PLC (GSK)? Yes — 58.66M shares worth $3.2B (+1.78% of its 13F portfolio) as of Q1 2026, down from 68.52M shares the prior filed quarter.
Position Value
$3.2B
Q1 2026
Shares
58.66M
% of Portfolio
+1.78%
Quarters Held
15
currently held
Position History GSK
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 58.66M | $3.2B | +1.78% |
| Q4 2025 | 68.52M | $3.4B | +1.81% |
| Q3 2025 | 78.40M | $3.4B | +1.83% |
| Q2 2025 | 78.76M | $3.0B | +1.70% |
| Q1 2025 | 78.65M | $3.0B | +1.74% |
| Q4 2024 | 68.44M | $2.3B | +1.35% |
| Q3 2024 | 68.09M | $2.8B | +1.57% |
| Q2 2024 | 68.34M | $2.6B | +1.58% |
| Q1 2024 | 68.86M | $3.0B | +1.71% |
| Q4 2023 | 69.03M | $2.6B | +1.62% |
| Q3 2023 | 69.28M | $2.5B | +1.69% |
| Q2 2023 | 69.61M | $2.5B | +1.66% |
| Q1 2023 | 69.71M | $2.5B | +1.69% |
| Q4 2022 | 64.93M | $2.3B | +1.56% |
| Q3 2022 | 58.58M | $1.7B | +1.31% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Dodge & Cox’s full portfolio or all institutional holders of GSK.